Remarks At The Small Business Capital Formation Advisory Committee Meeting
The recent remarks from SEC Chairman Paul S. Atkins and Commissioners Hester Peirce and Mark Uyeda at the April 28, 2026, Small Business Capital Formation Advisory Committee (SBCFAC) meeting signal a unified, aggressive push toward deregulating the initial public offering (IPO) process. For the micro-cap and small-cap deal maker, these statements provide a roadmap for a more streamlined, cost-effective entry into the public markets. By prioritizing “financial materiality” over “regulatory creep,” the Commission is attempting to dismantle the barriers that have historically sidelined smaller issuers.
The “Minimum Effective Dose” Strategy: Atkins’ Consistent Vision
Chairman Paul Atkins’ remarks centered on his “minimum effective dose” (MED) philosophy, a concept he has consistently championed since taking the helm. This regulatory framework is predicated on the idea that the Commission should provide only the necessary amount of oversight required to protect investors while allowing businesses to flourish without unnecessary interference.
Atkins emphasized that disclosures should be governed by “financial materiality” as the “north
